Turbotodd

Ruminations on tech, the digital media, and some golf thrown in for good measure.

Archive for January 9th, 2017

IBM Inventors Receive Record-Breaking 8K+ U.S. Patents In 2016

leave a comment »

IBM today announced that it broke the U.S. patent record with 8,088 patents granted to its inventors in 2016, marking the 24th consecutive year of innovation leadership.

IBM’s 2016 patent output covers a diverse range of inventions in artificial intelligence and cognitive computing, cognitive health, cloud, cybersecurity and other strategic growth areas for the company.

IBM inventors were granted more than 22 patents per day in 2016, enabling the company to become the first to surpass 8,000 patents in a single year. IBM researchers, engineers, and designers generated more than 2,700 patents for inventions related to AI, cognitive computing and cloud computing.

More than 8,500 IBM inventors residing in 47 states and territories and 47 countries are responsible for IBM’s record-setting 2016 patent tally. IBM inventors based in New York received over 2,700 patents, while IBMers based in California and Texas were granted over 1,000 patents each.

The United States is home to more than half of IBM’s $5.4 billion annual investment in research and development. This substantial commitment to unlocking new technologies is what has long propelled IBM into new markets, allowing it to create value for clients and opportunity for its employees, including the 25,000 Americans the company has pledged to hire over the next four years.

Written by turbotodd

January 9, 2017 at 10:05 am

IBM And Illumina Partner On Genomic Data

with one comment

IBM Watson Health and Illumina, Inc. have announced a major partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina’s BaseSpace®Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation.

By adding Watson for Genomics to Illumina’s next-generation sequencing platform, researchers who use Illumina’s cancer genome sequencing panel will have rapid access to information to help interpret the broad array of variant data produced by TruSight Tumor 170. Illumina’s TruSight® Tumor 170 is a solid tumor profiling panel designed to detect a comprehensive set of variants across 170 genes.

In a matter of minutes, Watson for Genomics will read the genetic alteration files produced by TruSight Tumor 170, comb professional guidelines, medical literature, clinical trials compendia, and other sources of knowledge to provide information for each genomic alteration, and produce a report for use by researchers — a process that typically takes scientists more than one week to complete.

Watson for Genomics ingests data from approximately 10,000 scientific articles and 100 new clinical trials every month. The Watson for Genomics software will be available to support Illumina’s TruSight Tumor 170 assay early in 2017.

Cancer is a leading cause of death worldwide and a growing body of research shows that analyzing the genomic basis of a tumor can be important for understanding the individual patient’s disease, a major aspect of precision medicine.

However, the output of next generation sequencing panels requires sophisticated analyses to help identify the mutations responsible for cancer growth and correlate that information with potential standard and experimental treatment options. This is where Watson is expected to help.

“To enable precision cancer medicine on a large scale, we need new tools to overcome the data barriers of genomic research,” said Francis deSouza, President and CEO of Illumina.. “With a comprehensive assay of Illumina and the power of Watson, we hope to deliver a rapid turnaround of the genomic alteration results.”

Genome sequencing has increased in recent years following two decades of research demonstrating the promise of precision medicine. However, access to these advances has been limited by the significant time and expense required to interpret the genomic data.

Written by turbotodd

January 9, 2017 at 9:12 am

%d bloggers like this: